GlassScriptPhysician profile
Jody M Neer
NPI 1720085210
$3,111.75
in general payments reported to CMS, 2019-2025
41 companies · $561 in 2025
The $561 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $838 · 2020: $339 · 2021: $131 · 2022: $210 · 2023: $508 · 2024: $526 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,540 · Education: $54.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,539.79 |
| Education | $54.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $499.04 | 2019-2025 | |
| Ucb, INC. | $275.15 | 2021-2025 | Briviact, Rystiggo |
| Biogen, INC. | $247.80 | 2019-2023 | Vumerity |
| Supernus Pharmaceuticals, INC. | $207.81 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $192.10 | 2019-2025 | |
| Neurelis, INC. | $167.99 | 2022-2023 | Valtoco |
| Catalyst Pharmaceuticals, INC. | $122.41 | 2024 | |
| Jazz Pharmaceuticals INC. | $119.38 | 2024 | |
| Eisai INC. | $102.64 | 2019-2025 | |
| Allergan, INC. | $74.50 | 2019-2021 | |
| Genzyme Corporation | $73.16 | 2019-2020 | |
| Pfizer INC. | $63.27 | 2023-2025 | |
| Livanova USA, INC. | $61.81 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Acorda Therapeutics, INC | $60.70 | 2019-2020 | |
| Lundbeck LLC | $59.26 | 2019-2024 | Vyepti |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jody Neer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.